Albion Financial Group Accelerate Diagnostics, Inc Transaction History

Albion Financial Group

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 19, 2021	BUY	$7.04 - $11.7 $14,960 - $24,862	2,125 New	2,125 $16,000
Q4 2019 Jan 31, 2020	SELL	$14.6 - $18.13 $158,526 - $196,855	-10,858 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$11.76 - $22.15 $88,788 - $167,232	-7,550 Reduced 41.01%	10,858 $228,000
Q4 2018 Jan 28, 2019	SELL	$10.42 - $21.94 $106,805 - $224,885	-10,250 Reduced 35.77%	18,408 $212,000
Q3 2018 Nov 20, 2018	SELL	$20.4 - $24.6 $131,580 - $158,670	-6,450 Reduced 18.37%	28,658 $658,000
Q2 2018 Aug 15, 2018	SELL	$19.02 - $24.95 $355,103 - $465,816	-18,670 Reduced 34.72%	35,108 $783,000
Q1 2018 Apr 17, 2018	SELL	$22.55 - $29.9 $72,160 - $95,680	-3,200 Reduced 5.62%	53,778 $1.23 Million
Q4 2017 Feb 22, 2018	SELL	$18.0 - $30.0 $23,400 - $39,000	-1,300 Reduced 2.23%	56,978 $1.49 Million
Q2 2017 Aug 15, 2017	BUY	N/A	58,278	58,278 $1.59 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

Stay updated on Albion Financial Group with notifications on news.